[Long-term clinical study of a new molecule (nifedipine) in ischemic cardiopathy].
Results with a new anti-angina molecule (nifedipine: Adalat) in the long-term management of 28 patients with ischaemic heart disease are presented. The effectiveness of the drug was judged outstanding on the strength of its reduction of angina outstanding on the strength of its reduction of angina crises and consumption of NTG beads. Non side-effects were noted.
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
D011725:Pyridines; D009543:Nifedipine
Studio clinico a lungo termine di una nuova molecola (nifedipina) nella cardiopatia ischemica.